{"address1": "3891 Ranchero Drive", "address2": "Suite 150", "city": "Ann Arbor", "state": "MI", "zip": "48108", "country": "United States", "phone": "734 887 3903", "website": "https://www.esperion.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.", "fullTimeEmployees": 304, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sheldon L. Koenig", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 1278804, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric J. Warren R.Ph.", "age": 52, "title": "Chief Commercial Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 718859, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Benjamin  Halladay M.B.A.", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Glenn P. Brame", "age": 66, "title": "Chief Technical Operations Officer", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Benjamin O. Looker J.D.", "age": 42, "title": "General Counsel & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 550350, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Tiffany  Aldrich M.B.A.", "title": "Associate Director of Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Betty Jean Swartz", "title": "Chief Business Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 4, "compensationRisk": 7, "shareHolderRightsRisk": 9, "overallRisk": 6, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.44, "open": 1.451, "dayLow": 1.35, "dayHigh": 1.455, "regularMarketPreviousClose": 1.44, "regularMarketOpen": 1.451, "regularMarketDayLow": 1.35, "regularMarketDayHigh": 1.455, "payoutRatio": 0.0, "beta": 1.042, "forwardPE": 7.0499997, "volume": 4958409, "regularMarketVolume": 4958409, "averageVolume": 4250910, "averageVolume10days": 3974210, "averageDailyVolume10Day": 3974210, "bid": 1.37, "ask": 1.44, "bidSize": 10, "askSize": 10, "marketCap": 278967072, "fiftyTwoWeekLow": 1.35, "fiftyTwoWeekHigh": 3.94, "priceToSalesTrailing12Months": 0.83946836, "fiftyDayAverage": 1.751, "twoHundredDayAverage": 2.08735, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 725417920, "profitMargins": -0.15571, "floatShares": 195662656, "sharesOutstanding": 197848992, "sharesShort": 28900005, "sharesShortPriorMonth": 28100794, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1461, "heldPercentInsiders": 0.0100300005, "heldPercentInstitutions": 0.65700996, "shortRatio": 7.27, "shortPercentOfFloat": 0.14649999, "impliedSharesOutstanding": 197848992, "bookValue": -1.985, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -51745000, "trailingEps": -0.28, "forwardEps": 0.2, "enterpriseToRevenue": 2.183, "enterpriseToEbitda": 13.319, "52WeekChange": -0.5480769, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.41, "targetHighPrice": 16.0, "targetLowPrice": 2.05, "targetMeanPrice": 6.63125, "targetMedianPrice": 5.0, "recommendationMean": 2.11111, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 144760992, "totalCashPerShare": 0.732, "ebitda": 54465000, "totalDebt": 591212032, "quickRatio": 0.913, "currentRatio": 1.373, "totalRevenue": 332313984, "revenuePerShare": 1.775, "returnOnAssets": 0.123730004, "grossProfits": 217475008, "freeCashflow": -43618624, "operatingCashflow": -23654000, "revenueGrowth": 1.143, "grossMargins": 0.65443003, "ebitdaMargins": 0.16389999, "operatingMargins": -0.06395, "financialCurrency": "USD", "symbol": "ESPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Esperion Therapeutics, Inc.", "regularMarketChange": -0.03000009, "regularMarketDayRange": "1.35 - 1.455", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 4250910, "fiftyTwoWeekLowChange": 0.059999943, "fiftyTwoWeekLowChangePercent": 0.0444444, "fiftyTwoWeekRange": "1.35 - 3.94", "fiftyTwoWeekHighChange": -2.5300002, "fiftyTwoWeekHighChangePercent": -0.64213204, "fiftyTwoWeekChangePercent": -54.807693, "earningsTimestamp": 1741086000, "earningsTimestampStart": 1746448200, "earningsTimestampEnd": 1746793800, "earningsCallTimestampStart": 1741093200, "earningsCallTimestampEnd": 1741093200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.28, "epsForward": 0.2, "epsCurrentYear": -0.03333, "priceEpsCurrentYear": -42.30423, "fiftyDayAverageChange": -0.34100008, "fiftyDayAverageChangePercent": -0.1947459, "twoHundredDayAverageChange": -0.6773499, "twoHundredDayAverageChangePercent": -0.32450235, "priceToBook": -0.71032745, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.1 - Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1372253400000, "preMarketChange": 0.05000007, "preMarketChangePercent": 3.5461044, "preMarketPrice": 1.46, "longName": "Esperion Therapeutics, Inc.", "corporateActions": [], "preMarketTime": 1743580993, "regularMarketTime": 1743537600, "exchange": "NGM", "messageBoardId": "finmb_28236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "cryptoTradeable": false, "regularMarketChangePercent": -2.0833395, "regularMarketPrice": 1.41, "marketState": "PRE", "displayName": "Esperion Therapeutics", "trailingPegRatio": null}